Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT-Reference-Cited by-同舟云学术

Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT

Published:2017-10 Issue:5 Volume:15 Page:e773-e782
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Bouman-Wammes Esther W.,van Dodewaard-De Jong Joyce M.,Dahele Max,Cysouw Matthijs C.F.,Hoekstra Otto S.,van Moorselaar R. Jeroen A.,Piet Maartje A.H.,Verberne Hein J.,Bins Adriaan D.,Verheul Henk M.W.,Slotman Ben J.,Oprea-Lager Daniela E.,Van den Eertwegh Alfons J.M.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference32 articles.

1. Global incidence and mortality for prostate cancer: analysis of temporal patterns and trends in 36 countries;Wong;Eur Urol,2016

2. EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing and castration resistant prostate cancer;Heidenreich;Eur Urol,2014

3. Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data;Vale;Lancet Oncol,2016

4. Androgen deprivation therapy in men with prostate cancer; how should the side effects be monitored and treated?;Grossmann;Clin Endocrinol (Oxf),2011

5. Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer;Taylor;Cancer,2009

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Five‐year outcomes of fractionated stereotactic body radiotherapy for oligometastatic prostate cancer from the TRANSFORM phase II trial;International Journal of Cancer;2024-06-19

2. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions;Journal of Urology;2024-04

3. Metabolic response after 68Ga-PSMA-PET/CT-directed IGRT/SBRT for oligometastases prostate cancer;Clinical and Translational Oncology;2022-11-11

4. Oligometastatic Prostate Cancer: Current Status and Future Challenges;Journal of Nuclear Medicine;2022-11

5. Role of Local Treatment for Oligometastasis: A Comparability Based Meta-Analysis;Cancer Research and Treatment;2022-10-15